Rheumatoid arthritis treatment involves medications that suppress the immune system by targeting specific proteins. Trial and error determines the effectiveness of biologics, while traditional drugs like methotrexate affect the immune system more generally. This risk-reward approach, dating back to mathematician Daniel Bernoulli, applies to modern medications, with patients weighing relief against potential risks.